Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Healthtrust
Citi
Harvard Business School
Fuji
Deloitte
Federal Trade Commission
Teva
Cantor Fitzgerald

Generated: December 10, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR RIDAURA

« Back to Dashboard

Clinical Trials for Ridaura

Trial ID Title Status Sponsor Phase Summary
NCT01419691 Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) Completed Kansas Bioscience Authority Phase 2 The purpose of this study is to evaluate the safety and effectiveness of auranofin to treat patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or prolymphocytic lymphoma (PLL).
NCT01419691 Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) Completed The Leukemia and Lymphoma Society Phase 2 The purpose of this study is to evaluate the safety and effectiveness of auranofin to treat patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or prolymphocytic lymphoma (PLL).
NCT01419691 Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) Completed Therapeutics for Rare and Neglected Diseases (TRND) Phase 2 The purpose of this study is to evaluate the safety and effectiveness of auranofin to treat patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or prolymphocytic lymphoma (PLL).
NCT01419691 Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) Completed University of Kansas Medical Center Phase 2 The purpose of this study is to evaluate the safety and effectiveness of auranofin to treat patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or prolymphocytic lymphoma (PLL).
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Ridaura

Condition Name

Condition Name for Ridaura
Intervention Trials
Squamous Cell Lung Carcinoma 1
HIV 1
Recurrent Non-small Cell Lung Cancer 1
Small Lymphocytic Lymphoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Ridaura
Intervention Trials
Lung Neoplasms 2
Carcinoma, Non-Small-Cell Lung 2
Ovarian Neoplasms 2
Leukemia, Prolymphocytic 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Ridaura

Trials by Country

Trials by Country for Ridaura
Location Trials
United States 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Ridaura
Location Trials
Minnesota 3
Florida 2
Arizona 1
Kansas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Ridaura

Clinical Trial Phase

Clinical Trial Phase for Ridaura
Clinical Trial Phase Trials
Phase 2 2
Phase 1/Phase 2 2
Phase 1 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Ridaura
Clinical Trial Phase Trials
Withdrawn 2
Active, not recruiting 2
Recruiting 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Ridaura

Sponsor Name

Sponsor Name for Ridaura
Sponsor Trials
Mayo Clinic 5
National Cancer Institute (NCI) 4
University of Kansas Medical Center 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Ridaura
Sponsor Trials
Other 10
NIH 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
UBS
Teva
Farmers Insurance
Merck
Harvard Business School
Johnson and Johnson
Cantor Fitzgerald
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.